The Insomnia Trap: Stop Treating Every Sleepless Psychiatric Patient the Same

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

What do you do when your psychiatric patient is depressed, anxious, traumatized—or struggling with ADHD—and also tells you they can’t sleep?

This is one of the most common clinical dilemmas new psychiatric nurse practitioners and PMHNP students encounter. Your patient needs treatment for depression or anxiety, but you know an SSRI or SNRI may initially feel activating. They’re already exhausted. They want to sleep tonight. So do you add trazodone? Choose mirtazapine? Try low-dose doxepin or ramelteon? Start the SSRI and wait? Or are you treating the wrong problem entirely?

In this episode of Pearls and Prep, NPZ breaks down a more methodical way to think about insomnia in psychiatric practice: before treating sleeplessness, figure out what is actually keeping the patient awake.

Insomnia is incredibly transdiagnostic. A patient with major depressive disorder may lie awake ruminating about the past, guilt, worthlessness, or perceived failures. A patient with an anxiety disorder may be forecasting everything that could go wrong tomorrow. PTSD may produce hyperarousal, hypervigilance, nightmares, and a nervous system that never seems to feel safe enough to shut down. ADHD can create a different nighttime experience altogether—unfinished tasks, forgotten emails, executive dysfunction, and the feeling that the brain simply won’t turn off.

Those differences matter because they can change your treatment strategy.

We discuss why successfully treating the underlying psychiatric disorder with an SSRI or SNRI can sometimes improve sleep without the medication itself being sedating. We also explore situations where mirtazapine (Remeron) may give you multiple therapeutic advantages at once—particularly when depression or anxiety occurs alongside insomnia and poor appetite—and why duloxetine (Cymbalta) may deserve consideration when pain is one of the major reasons your patient cannot sleep.

Then we tackle the harder question: what if treating the underlying condition isn’t enough?

We walk through CBT-I and why cognitive behavioral therapy for insomnia needs to remain part of the conversation, while also acknowledging the real-world barriers psychiatric clinicians encounter when patients cannot access it, cannot afford it, don’t have time for it, or simply want relief now.